A broad upregulation of cerebral chemokine genes by peripherally-generated inflammatory mediators.
Previously, we have shown that peripheral challenge of mice with double stranded RNA (dsRNA), a viral mimic, evokes global upregulation of cerebral inflammatory genes and, particularly, genes encoding chemokines. Because chemokine networks are potent modulators of brain function, the present study was undertaken to comprehensively characterize the cerebral response of chemokine ligand and receptor genes to peripheral immune system stimulation. Briefly, C57BL/6 mice were intraperitoneally injected with 12 mg/kg of polyinosinic-polycytidylic acid (PIC) and the expression of 39 mouse chemokine ligand and 20 receptor genes was monitored in the cerebellum by real time quantitative RT-PCR within 24 h. Almost half of the ligand genes featured either transient or sustained upregulation from several- to several thousand-fold. Five CXC type genes, i.e., Cxcl9, Cxcl11, Cxcl10, Cxcl2 and Cxcl1, were the most robustly upregulated, and were followed by six CC type genes, i.e., Ccl2, Ccl7, Ccl5, Ccl12, Ccl4 and Ccl11. Seven genes showed moderate upregulation, whereas the remaining genes were unresponsive. Six receptor genes, i.e., Cxcr2, Ccr7, Cxcr5, Ccr6, Ccr1 and Ccr5, featured a several-fold upregulation. Similar chemokine gene response was observed in the forebrain and brainstem. This upregulation of chemokine genes could be induced in naïve mice by transfer of blood plasma from PIC-challenged mice. Employing oligodeoxynucleotide-labeled PIC we further showed that intraperitoneally injected PIC was not transferred to the blood. In conclusion, peripheral PIC challenge elicits a broad upregulation of cerebral chemokine genes, and this upregulation is mediated by blood-borne agents.
Department of Neurobiology and Anatomy, West Virginia University School of Medicine, 4052 HSN, P.O. Box 9128, Morgantown, WV 26506-9128, USA.
Daniel
D
Fil
Elizabeth
E
Borysiewicz
Gregory W
GW
Konat
D000818:Animals; D001921:Brain / Q000378:metabolism*; D019742:Chemokines, CC / Q000235:genetics / Q000378:metabolism*; D019743:Chemokines, CXC / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D018836:Inflammation Mediators / Q000097:blood / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D011070:Poly I-C / Q000008:administration & dosage*; D019707:Receptors, Chemokine / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015854:Up-Regulation
D019742:Chemokines, CC; D019743:Chemokines, CXC; D018836:Inflammation Mediators; D019707:Receptors, Chemokine; D011070:Poly I-C
J Neuroimmunol. 1997 Apr;74(1-2):35-44
9119977
J Neurochem. 2002 Apr;81(2):257-69
12064472
AAPS J. 2006 Jan 06;7(4):E865-70
16594639
J Interferon Cytokine Res. 2002 Oct;22(10):1067-8
12433287
Brain Res Bull. 1991 Nov;27(5):701-6
1756389
J Neurochem. 2001 Sep;78(5):960-71
11553670
J Interferon Cytokine Res. 1997 Apr;17(4):197-204
9142648
J Neuroimmunol. 1994 Feb;50(1):101-7
8300851
Endothelium. 1997;5(3):143-53
9272378
Glia. 2007 Dec;55(16):1728-39
17902170
J Neuroimmunol. 2003 Sep;142(1-2):1-9
14512159
Am J Pathol. 1997 Nov;151(5):1341-51
9358760
Neuropathol Appl Neurobiol. 2010 Aug;36(5):368-87
20487305
J Immunol. 1996 Apr 15;156(8):3017-23
8609424
Life Sci. 2004 Apr 2;74(20):2563-76
15010266
Neurochem Res. 1993 Jun;18(6):667-73
8510794
Science. 1989 Feb 24;243(4894 Pt 1):1066-8
2646711
Am J Physiol. 1994 May;266(5 Pt 2):R1711-5
7515592
J Neurochem. 2010 Sep 1;114(5):1277-90
20534007
J Neuroimmunol. 2010 Dec 15;229(1-2):73-80
20678811
Curr Med Chem. 2007;14(23):2456-70
17979699
J Neuroimmunol. 1998 Dec 1;92(1-2):122-32
9916887
J Neuroimmunol. 2009 Feb 15;207(1-2):92-100
19167097
J Neuroimmunol. 2004 May;150(1-2):37-47
15081247
Virology. 1996 May 15;219(2):339-49
8638399
Brain Behav Immun. 2007 Aug;21(6):727-35
17604598
J Physiol. 1996 Feb 15;491 ( Pt 1):209-17
9011612
Neurol Clin. 2006 Aug;24(3):441-60
16877117
J Immunol. 1996 Jun 1;156(11):4363-8
8666808
J Neurosci. 2008 Nov 12;28(46):11792-5
19005041
Glia. 2006 Jan 1;53(1):24-31
16086366
J Neuroimmunol. 2000 Aug 1;108(1-2):227-35
10900358
EMBO J. 2001 May 15;20(10):2497-507
11350939
Curr Pharm Des. 2006;12(24):3101-15
16918437
Annu Rev Immunol. 2004;22:891-928
15032599
Dev Comp Immunol. 2004 May 3;28(5):443-60
15062643
Glia. 2002 Nov;40(2):140-55
12379902
Nature. 1998 Apr 9;392(6676):565-8
9560152
J Neuroimmunol. 2008 Jul 31;198(1-2):62-8
18538863
J Neurochem. 2002 Sep;82(6):1311-29
12354279
J Neurochem. 2005 Nov;95(4):1023-34
16150057
Life Sci. 2003 Mar 7;72(16):1825-39
12586220
J Neurovirol. 1999 Feb;5(1):82-94
10190694
Neurobiol Dis. 2006 May;22(2):312-22
16472549
J Neurosci. 2001 Jul 15;21(14):5027-35
11438578
J Comp Neurol. 2007 Feb 20;500(6):1007-33
17183554
J Cereb Blood Flow Metab. 2001 Jan;21(1):69-76
11149670
Auton Neurosci. 2000 Dec 20;85(1-3):133-40
11189020
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):387-99
16101548
J Virol. 2005 Jul;79(13):8295-302
15956575
Neuroscience. 2009 Sep 15;162(4):1072-80
19477239
Front Neuroendocrinol. 2011 Jan;32(1):10-24
20624414
Acta Biomed. 2007;78 Suppl 1:231-47
17465337
J Clin Invest. 1999 Mar;103(6):807-15
10079101
J Neurovirol. 1999 Feb;5(1):3-12
10190685
Trends Neurosci. 2007 Nov;30(11):596-602
17950926
J Immunol. 1997 Mar 15;158(6):2882-90
9058825
Neuroreport. 1998 Nov 16;9(16):3601-6
9858367
Am J Physiol. 1997 Dec;273(6):R1870-7
9435639
Glia. 2008 Aug 1;56(10):1104-13
18442092
J Leukoc Biol. 2000 Jul;68(1):1-8
10914483
J Immunol. 1998 Jan 15;160(2):970-8
9551936
Fundam Clin Pharmacol. 2004 Apr;18(2):163-9
15066130
J Neuroimmunol. 2002 Aug;129(1-2):66-73
12161022
J Clin Invest. 1999 Nov;104(10):1333-4
10562292
Annu Rev Immunol. 2007;25:787-820
17291188
Nat Rev Neurosci. 2008 Jan;9(1):46-56
18073775
Front Neuroendocrinol. 2001 Jul;22(3):147-84
11456467
J Immunol. 1998 Feb 1;160(3):1449-55
9570566
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14500-5
9826729
Brain Res. 2001 Jun 1;902(2):171-7
11384610
J Neuroimmunol. 2004 Nov;156(1-2):74-87
15465598
Curr Opin Investig Drugs. 2006 Jul;7(7):643-6
16869118
J Neurosci Res. 2007 Jan;85(1):205-12
17061254
Brain Res Bull. 1991 Aug;27(2):273-8
1742616
Ann N Y Acad Sci. 2006 Nov;1088:230-7
17192569
J Virol. 2005 Sep;79(17):11457-66
16103196
Nat Rev Neurosci. 2003 Jun;4(6):444-55
12778117
Brain Behav Immun. 2007 May;21(4):490-502
17321719
Neuroreport. 2002 Oct 28;13(15):1921-4
12395092
J Neuroimmunol. 2003 Mar;136(1-2):84-93
12620646
J Neurosci Res. 2009 May 1;87(6):1381-8
19115408
N Engl J Med. 2006 Feb 9;354(6):610-21
16467548
Brain Res. 2007 Aug 3;1161:21-31
17604006
Br J Pharmacol. 2006 Jan;147 Suppl 1:S212-21
16402107
Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R759-66
15205185
FASEB J. 2001 Feb;15(2):383-92
11156954
Glia. 2000 Feb 1;29(3):273-80
10642753
J Comp Neurol. 2003 Feb 24;457(1):7-23
12541321
Neuroscience. 2002;112(3):487-97
12074892
Eur J Pharmacol. 2004 Oct 1;500(1-3):399-411
15464048
FASEB J. 1993 Apr 1;7(6):592-600
8472896
Brain Res Brain Res Rev. 2005 Feb;48(1):16-42
15708626
J Neuroimmunol. 1995 Mar;57(1-2):193-8
7706436
J Leukoc Biol. 2005 Dec;78(6):1204-9
16204637
Annu Rev Immunol. 2000;18:217-42
10837058
J Neuroimmunol. 1995 Jul;60(1-2):143-50
7642742
J Virol. 2006 May;80(10):5059-64
16641297
Eur J Neurosci. 2005 Dec;22(11):2817-26
16324116
Glia. 2008 Apr;56(5):568-78
18240301